Related references
Note: Only part of the references are listed.Different randomized multiple-baseline models for different situations: A practical guide for single-case intervention researchers
Joel R. Levin et al.
JOURNAL OF SCHOOL PSYCHOLOGY (2021)
Systematic Review of N-of-1 Studies in Rare Genetic Neurodevelopmental Disorders The Power of 1
Annelieke R. Mueller et al.
NEUROLOGY (2021)
Murray Sidman's contributions to clinical behavior analysis
Michael J. Dougher
JOURNAL OF THE EXPERIMENTAL ANALYSIS OF BEHAVIOR (2021)
Trial of restarting and tolerating metformin (TreatMet)
Jeremy N. Orloff et al.
DIABETES OBESITY & METABOLISM (2020)
N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects
Frances A. Wood et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
From Boulder to Stockholm in 70 Years: Single Case Experimental Designs in Clinical Research
Johan W. S. Vlaeyen et al.
PSYCHOLOGICAL RECORD (2020)
Analysing N-of-1 observational data in health psychology and behavioural medicine: a 10-step SPSS tutorial for beginners
Suzanne McDonald et al.
HEALTH PSYCHOLOGY AND BEHAVIORAL MEDICINE (2020)
Designing Robust N-of-1 Studies for Precision Medicine
Bethany Percha et al.
JOURNAL OF MEDICAL INTERNET RESEARCH (2019)
RD-RAP: beyond rare disease patient registries, devising a comprehensive data and analytic framework
Matthew I. Bellgard et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
Drug Regulation in the Era of Individualized Therapies
Janet Woodcock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Ethical justification of single-blind and double-blind placebo-controlled response tests in neuropathic pain and N-of-1 treatment paradigm in clinical settings
Jan M. Keppel Hesselink et al.
JOURNAL OF PAIN RESEARCH (2019)
Making the switch: From case studies to N-of-1 trials
Amanda Margolis et al.
EPILEPSY & BEHAVIOR REPORTS (2019)
Comparison of Aggregated N-of-1 Trials with Parallel and Crossover Randomized Controlled Trials Using Simulation Studies
J. Walker Blackston et al.
HEALTHCARE (2019)
On-Demand Sildenafil as a Treatment for Raynaud Phenomenon A Series of n-of-1 Trials
Matthieu Roustit et al.
ANNALS OF INTERNAL MEDICINE (2018)
Effect of Mexiletine on Muscle Stiffness in Patients With Nondystrophic Myotonia Evaluated Using Aggregated N-of-1 Trials
Bas C. Stunnenberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
N-of-1 Randomized Intervention Trials in Health Psychology: A Systematic Review and Methodology Critique
Jonathan A. Shaffer et al.
ANNALS OF BEHAVIORAL MEDICINE (2018)
Single-case experimental designs to assess intervention effectiveness in rehabilitation: A practical guide
Agata Krasny-Pacini et al.
ANNALS OF PHYSICAL AND REHABILITATION MEDICINE (2018)
The Single-Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016 Statement
Robyn L. Tate et al.
NEUROPSYCHOLOGICAL REHABILITATION (2017)
The history and development of N-of-1 trials
R. D. Mirza et al.
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2017)
A series of n-of-1 trials of stimulants in brain injured children
Jane Nikles et al.
NEUROREHABILITATION (2017)
Dynamic modelling of n-of-1 data: powerful and flexible data analytics applied to individualised studies
Rute Vieira et al.
HEALTH PSYCHOLOGY REVIEW (2017)
The state of the art and future opportunities for using longitudinal n-of-1 methods in health behaviour research: a systematic literature overview
Suzanne McDonald et al.
HEALTH PSYCHOLOGY REVIEW (2017)
How Can Single-Case Data Be Analyzed? Software Resources, Tutorial, and Reflections on Analysis
Rumen Manolov et al.
BEHAVIOR MODIFICATION (2017)
CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement
Sunita Vohra et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
N-of-1 trials are a tapestry of heterogeneity
Salima Punja et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
Do N-of-1 Trials Need IRB Review?
Ruiqi Cen et al.
JOURNAL OF EMPIRICAL RESEARCH ON HUMAN RESEARCH ETHICS (2016)
Statin Intolerance: the Clinician's Perspective
Tomas Stulc et al.
CURRENT ATHEROSCLEROSIS REPORTS (2015)
Single-Case Research Methods: History and Suitability for a Psychological Science in Need of Alternatives
Camilo Hurtado-Parrado et al.
INTEGRATIVE PSYCHOLOGICAL AND BEHAVIORAL SCIENCE (2015)
The Effect of Methylphenidate on Fatigue in Advanced Cancer: An Aggregated N-of-1 Trial
Geoffrey K. Mitchell et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2015)
Time for one-person trials
Nicholas J. Schork
NATURE (2015)
CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement
Sunita Vohra et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement
Sunita Vohra et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Aggregated n-of-1 trials of central nervous system stimulants versus placebo for paediatric traumatic brain injury - a pilot study
Catherine J. Nikles et al.
TRIALS (2014)
What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice
Judith A. Finegold et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2014)
Revision of a method quality rating scale for single-case experimental designs and n-of-1 trials: The 15-item Risk of Bias in N-of-1 Trials (RoBiNT) Scale
Robyn L. Tate et al.
NEUROPSYCHOLOGICAL REHABILITATION (2013)
Mexiletine for Symptoms and Signs of Myotonia in Nondystrophic Myotonia A Randomized Controlled Trial
Jeffrey M. Statland et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Single-Case Experimental Designs: A Systematic Review of Published Research and Current Standards
Justin D. Smith
PSYCHOLOGICAL METHODS (2012)
Aggregating single patient (n-of-1) trials in populations where recruitment and retention was difficult: The case of palliative care
Jane Nikles et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
N-of-1 Trials in the Medical Literature A Systematic Review
Nicole B. Gabler et al.
MEDICAL CARE (2011)
Using N-of-1 Trials to Improve Patient Management and Save Costs
Paul A. Scuffham et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2010)
N-of-1 Randomized Trials to Assess the Efficacy of Gabapentin for Chronic Neuropathic Pain
Michael J. Yelland et al.
PAIN MEDICINE (2009)
What Ever Happened to N-of-1 Trials? Insiders' Perspectives and a Look to the Future
Richard L. Kravitz et al.
MILBANK QUARTERLY (2008)
Are N-of-1 trials and economically viable option to improve access to selected high cost medications? The Australian experience
Paul A. Scuffham et al.
VALUE IN HEALTH (2008)
Long-term changes in management following n-of-1 trials of stimulants in attention-deficit/hyperactivity disorder
C. Jane Nikles et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Celecoxib compared with sustained-release paracetamol for osteoarthritis: a series of n-of-1 trials
M. J. Yelland et al.
RHEUMATOLOGY (2007)
An n-of-1 trial service in clinical practice:: Testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder
C. Jane Nikles et al.
PEDIATRICS (2006)